AESICA QUEENBOROUGH LIMITED

06350087
Dissolved Cheadle

Manufacture of basic pharmaceutical products

277 employees website.com
Manufacture of basic pharmaceutical products
A

AESICA QUEENBOROUGH LIMITED

06350087

Manufacture of basic pharmaceutical products

Founded 22 Aug 2007 Dissolved Cheadle, England 277 employees website.com
Manufacture of basic pharmaceutical products
Accounts Submitted 5 Dec 2024 Next due 31 Mar 2025 16 months overdue
Confirmation
Net assets £15M £27M 2022 year on year
Total assets £35M £20M 2022 year on year
Total Liabilities £20M £7M 2022 year on year
Charges 10
10 satisfied

Contact & Details

Contact

Registered Address

C/O Pure Offices Suite 71 Brooks Drive Cheadle Royal Business Park Cheadle England SK8 3TD England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for AESICA QUEENBOROUGH LIMITED (06350087), a dissolved company based in Cheadle, England. Incorporated 22 Aug 2007. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2022
Type full
Next accounts 30 Jun 2024
Due by 31 Mar 2025 16 months overdue

Balance Sheet & P&L (2013–2022)

Cash in Bank

£600.00k

Decreased by £2.60M (-81%)

Net Assets

£15.30M

Decreased by £27.10M (-64%)

Total Liabilities

£19.70M

Increased by £7.10M (+56%)

Turnover

£26.80M

Decreased by £9.00M (-25%)

Employees

277

Decreased by 10 (-3%)

Debt Ratio

56%

Increased by 33 (+143%)

Financial History

Revenue, profit, EBITDA and key financial figures

2022
31 Dec Year End
2021
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 1

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 46,437,599 Shares £54.94m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
8 Apr 20252£8.50m£8.50m
30 Sept 202146,437,597£46.44m£1

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Consort Medical Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased
Active
Notified 20 Oct 2020
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors
Ceased

Group Structure

Group Structure

AESICA QUEENBOROUGH LIMITED Current Company

Charges

Charges

10 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
8 Jun 2026InsolvencyLiquidation Voluntary Statement Of Receipts And Payments With Brought Down Date
13 May 2025OfficersTermination of Gregor Johann Kawaletz as director on 6 May 2025
2 May 2025ResolutionResolutions
2 May 2025InsolvencyLiquidation Voluntary Appointment Of Liquidator
2 May 2025InsolvencyLiquidation Voluntary Declaration Of Solvency
8 Jun 2026 Insolvency

Liquidation Voluntary Statement Of Receipts And Payments With Brought Down Date

13 May 2025 Officers

Termination of Gregor Johann Kawaletz as director on 6 May 2025

2 May 2025 Resolution

Resolutions

2 May 2025 Insolvency

Liquidation Voluntary Appointment Of Liquidator

2 May 2025 Insolvency

Liquidation Voluntary Declaration Of Solvency

Recent Activity

Latest Activity

Liquidation Voluntary Statement Of Receipts And Payments With Brought Down Date

2 weeks ago on 8 Jun 2026

Termination of Gregor Johann Kawaletz as director on 6 May 2025

1 years ago on 13 May 2025

Resolutions

1 years ago on 2 May 2025

Liquidation Voluntary Appointment Of Liquidator

1 years ago on 2 May 2025

Liquidation Voluntary Declaration Of Solvency

1 years ago on 2 May 2025